The Role of PD-L1 Expression as a Predictive Biomarker in Advanced Non-Small-Cell Lung Cancer: A Network Meta-Analysis

2016163 citationsReview

Authors

Pedro Nazareth Aguiar · Universidade Federal de São Paulo

Ilka Lopes Santoro · Universidade Federal de São Paulo

Hakaru Tadokoro · Universidade Federal de São Paulo

Gilberto Lopes · Sociedade Brasileira de Oncologia Clínica

Bruno Andraus Filardi · Universidade Federal de São Paulo

Pedro F. Oliveira · Universidade do Porto

Giannis Mountzios

Abstract

Taking this data in account, PD-L1 overexpression could not be currently considered a robust biomarker to tailor the immune checkpoint inhibitors treatment.

Topics & Keywords

Lung Cancer Treatments and Mutations Cancer Immunotherapy and Biomarkers Lung Cancer Diagnosis and Treatment

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Immunotherapy

Volume 8, Issue 4, pp. 479-488

DOI: 10.2217/imt-2015-0002

Field-Weighted Citation Impact: 19.73